TGen Physician-In-Chief receives Distinguished Public Service Award from AACR

Dr. Daniel D. Von Hoff, Distinguished Professor and Physician-In-Chief for the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has been selected to receive the 2019 Distinguished Public Service Award from the American Association for Cancer Research (AACR). The AACR is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer.Continue reading

Beacon Biomedical Teams with National Phlebotomy Providers Network  To Launch a Nationwide Blood-Draw Service to Support BeScreened™-CRC

Despite being one of the most preventable cancers, colorectal cancer is the 2nd leading cause of cancer deaths among men and women in the United States. In 2018 alone, there were an estimated 140,250 new cases of colorectal cancer and 50,630 deaths.  While existing screening tests, such as fecal-based tests and colonoscopies, are extremely effective at finding colorectal cancer, they only work if they are used. 

 BeScreened™-CRC provides people the option for an easy, accurate & now convenient Blood Test for CRC Screening.Continue reading